Santhera Pharmaceuticals Holding AG Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG

SANN

Classificação em ações #16130
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company,... Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company’s lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Its clinical stage pipeline also comprises Lonodelestat for the treatment of cystic fibrosis and other neutrophilic pulmonary diseases. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.
Preço da ação
$19.25
Última sincronização: 2026-10-20
Valor de mercado
$294.54M
Variação (1 dia)
2.64%
Variação (1 ano)
50.03%
País
CH
Negociar Santhera Pharmaceuticals Holding AG (SANN)

Categoria

Healthcare
Histórico de rendimento de dividendos para Santhera Pharmaceuticals Holding AG (SANN)
O rendimento de dividendos (TTM) da Santhera Pharmaceuticals Holding AG (símbolo da ação: SANN) em 2026 é: 0
Rendimento médio dos dividendos nos últimos 5 anos: 0.00%
Histórico de rendimento de dividendos para Santhera Pharmaceuticals Holding AG (SANN) de 2026 a 2026
Rendimento de dividendos no final de cada ano (TTM)
Ano Rendimento de Dividendos Alterar
Não há dados suficientes para as datas fornecidas.
Rendimentos de dividendos (TTM) para empresas semelhantes ou concorrentes
Empresa Rendimento de Dividendos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.17%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL